Related Experiment Videos
Hypoxia-ischaemia model in the 7-day-old rat: possibilities and shortcomings
1Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Göteborg, Sweden.
Insights
The Levene model in immature rats simulates hypoxia-ischaemia (HI), offering a cost-effective platform for evaluating neuroprotective agents. This model allows for long-term assessment of brain injury outcomes in developing brains.
Area of Science:
- Neuroscience
- Developmental Biology
- Animal Models
Background:
- The Levene model is widely used for studying hypoxia-ischaemia (HI) in immature animals.
- The immature rat central nervous system resembles a term human infant's during the second postnatal week.
- This model presents differences from clinical asphyxia, including unilateral brain injury and absence of multi-organ dysfunction.
Purpose of the Study:
- To evaluate the utility of the Levene model for studying neonatal brain injury.
- To highlight the model's strengths and limitations in comparison to clinical scenarios.
- To underscore its suitability for dose-response studies of neuroprotective agents.
Main Methods:
- Utilizes a 7-day-old rat model to induce hypoxia-ischaemia.
- Characterizes the progressive nature of HI, including blood flow changes and metabolic derangements.
- Facilitates long-term neuropathological and functional outcome evaluations.
Main Results:
- The Levene model is well-characterized, easy to perform, and cost-effective.
- Allows for sufficient animal numbers for dose-response evaluations.
- Provides opportunities for long-term assessment of injury and recovery.
Conclusions:
- The Levene model is a valuable tool for investigating neonatal brain injury due to HI.
- Its progressive nature and similarities to birth asphyxia make it relevant for research.
- The model's cost-effectiveness and suitability for long-term studies support its continued use in neuroprotection research.
Abstract:
The Levene model in 7-day-old rats is the most often used model of hypoxia-ischaemia (HI) in immature animals. The rat central nervous system is immature at birth and corresponds neurodevelopmentally to the term human infant during the second postnatal week. The Levene model of HI differs from clinical asphyxia with respect to the unilateral distribution of brain injury and lack of multi-organ dysfunction. Furthermore, it does not allow cardiovascular monitoring or repeated blood sampling. On the other hand, the progressive nature of HI bears many similarities to birth asphyxia with regard to blood flow changes and cellular metabolic derangements. The model is well characterized, easy to carry out and the low cost allows inclusion of a sufficient number of animals for dose-response evaluation of neuroprotective agents. In addition, it provides the unique opportunity of long-term evaluation of neuropathological and functional outcome.